Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
The apoAI-CIII-AIV gene cluster, located on chromosome 11, contributes to the phenotype of familial combined hyperlipidemia (FCH), but this contribution is genetically complex. Combinations of haplotypes, based on three restriction enzyme polymorphisms: XmnI and MspI sites, 5′ of the start site of t...
Main Authors: | M. Groenendijk, R.M. Cantor, N.H.H.C. Blom, J.I. Rotter, T.W.A. de Bruin, G.M. Dallinga-Thie |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1999-06-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520335070 |
Similar Items
-
Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin
by: Geesje M. Dallinga-Thie, et al.
Published: (2001-09-01) -
CD14<sup>+</sup>-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor
by: Oliviero Olivieri, et al.
Published: (2023-01-01) -
Uncommon allele in APO AI-CIII-AIV gene cluster in a family with congenital generalized lipodystrophy
by: Estela Maria Novak, et al. -
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII
by: Oliviero Olivieri, et al.
Published: (2019-01-01) -
Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia
by: Chao Liu, et al.
Published: (2015-08-01)